Oaktree Acquisition III Life Sciences ROE 2025-2024 | OACC

Current and historical return on equity (ROE) values for Oaktree Acquisition III Life Sciences (OACC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Oaktree Acquisition III Life Sciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
$0.224B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
PicoCELA (PCLA) Japan $0.173B 0.00
Aduro Clean Technologies (ADUR) Canada $0.156B 0.00
Range Capital Acquisition (RANG) United States $0.140B 0.00
Tavia Acquisition (TAVI) $0.139B 0.00
CO2 Energy Transition (NOEM) $0.095B 0.00
Leishen Energy Holding (LSE) China $0.089B 0.00
YHN Acquisition I (YHNA) $0.081B 0.00
Youxin Technology (YAAS) $0.065B 0.00
YSX Tech (YSXT) China $0.062B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.026B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.019B 0.00
Sky Quarry (SKYQ) $0.016B 0.00
Flowco Holdings (FLOC) $0.000B 0.00